Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.

Fonseca PFS, Cançado RD, Naoum FA, Dinardo CL, Fonseca GHH, Gualandro SFM, Krieger JE, Pereira AC, Brissot P, Santos PCJL.

BMC Med Genet. 2018 Jan 5;19(1):3. doi: 10.1186/s12881-017-0513-5.

2.

Genetic discrimination and life insurance: a systematic review of the evidence.

Joly Y, Ngueng Feze I, Simard J.

BMC Med. 2013 Jan 31;11:25. doi: 10.1186/1741-7015-11-25. Review.

3.

Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study.

Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS; I-RESPOND-HD Investigators of the Huntington Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jul;153B(5):1081-93. doi: 10.1002/ajmg.b.31079.

4.

Biological variability of transferrin saturation and unsaturated iron-binding capacity.

Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, Leiendecker-Foster C, McLaren GD, Dawkins FW, Gordeuk VR, Lovato L, Eckfeldt JH.

Am J Med. 2007 Nov;120(11):999.e1-7.

5.

Screening in liver disease.

Del Poggio P, Mazzoleni M.

World J Gastroenterol. 2006 Sep 7;12(33):5272-80. Review.

6.

Normal iron metabolism and the pathophysiology of iron overload disorders.

Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK.

Clin Biochem Rev. 2006 Feb;27(1):5-16.

7.

Value of genetic testing in the management of pancreatitis.

Whitcomb DC.

Gut. 2004 Nov;53(11):1710-7. Review. No abstract available.

Supplemental Content

Support Center